Downregulation of YAP in Clear Cell Renal Cell Carcinoma Contributes to Poor Prognosis and Progressive Features.
To investigate the expression of Yes-associated protein (YAP) in clear cell renal cell carcinoma (ccRCC) and its clinical/prognostic significance. The expression of YAP protein was evaluated in tissue microarray by immunohistochemistry. Correlation between YAP expression and clinicopathological characteristics of renal cell carcinoma was analyzed. Downregulation of YAP protein was observed in ccRCC samples (P=0.0311). Downregulation of YAP expression was correlated with higher T classification, higher clinical stage, and poorer differentiation (P<0.05). Downregulation of YAP in clear cell renal cell carcinoma (ccRCC) may contribute to poor prognosis and progressive features.